KYMERA THERAPEUTICS I
42.21
07-10月-24 15:59:59
15 分の遅延
株式
-0.85
-1.97%
本日の幅
41.61 - 42.94
ISIN
N/A
ソース
NASDAQ
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
28 2 2024 07:00:10 提供 Nasdaq GlobeNewswire
-
22 2 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 22
15 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Present in Fireside Chat at the Guggenheim Healthcare Conference
31 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
09 1 2024 09:17:00 提供 Nasdaq GlobeNewswire
-
09 1 2024 09:15:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Pricing of $275 Million Public Offering
05 1 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Proposed Public Offering
04 1 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
02 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Host Virtual Immunology R&D Day on January 4
13 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
10 12 2023 21:00:00 提供 Nasdaq GlobeNewswire
-
13 11 2023 11:00:00 提供 Nasdaq GlobeNewswire
-
02 11 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Third Quarter 2023 Financial Results and Provides a Business Update
02 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
01 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Third Quarter 2023 Financial Results on November 2
26 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
16 10 2023 07:00:00 提供 Nasdaq GlobeNewswire